Randomized Pragmatic Clinical Trial On The Duration Of Antimicrobial Treatment For Enterobacteriaceae Bacteremia In Adult Patients (Shorten Study)

Gram-negative bacilli are responsible for frequent and potentially severe bloodstream infections, among which up to 47% can be produced by Enterobacteria (EB).The optimal duration of antibiotic treatment in this clinical setting is unknown, as no clinical trials (CT) have been designed to answer thi...

Full description

Saved in:
Bibliographic Details
Published inClinical therapeutics Vol. 37; no. 8; pp. e65 - e66
Main Authors Rosso-Fernández, C, Solano, B, Lavín-Alconero, L, Borrego, Y, Cisneros, J.M, Valiente, A, Natera, C, Molina, J
Format Journal Article
LanguageEnglish
Published Bridgewater Elsevier Inc 01.08.2015
Elsevier Limited
Subjects
Antibiotics
Antimicrobial agents
Internal Medicine
Medical Education
Pragmatism
Online AccessGet full text

Cover

More Information
Summary:Gram-negative bacilli are responsible for frequent and potentially severe bloodstream infections, among which up to 47% can be produced by Enterobacteria (EB).The optimal duration of antibiotic treatment in this clinical setting is unknown, as no clinical trials (CT) have been designed to answer this question. [...]the role of biomarkers such as procalcitonine (PCT) in this setting has not been established.
ISSN:0149-2918
1879-114X
DOI:10.1016/j.clinthera.2015.05.197